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Abstract  
245 words 
 
When validating risk models (or probabilistic classifiers), calibration is often 
overlooked. Calibration refers to the reliability of the predicted risks, i.e. whether the 
predicted risks correspond to observed probabilities. In medical applications this is 
important because treatment decisions often rely on the estimated risk of disease. 
The aim of this paper is to present generic tools to assess the calibration of 
multiclass risk models. 
 
We describe a calibration framework based on a vector spline multinomial logistic 
regression model. This framework can be used to generate calibration plots and 
calculate the estimated calibration index (ECI) to quantify lack of calibration. We 
illustrate these tools in relation to risk models used to characterize ovarian tumors. 
The outcome of the study is the surgical stage of the tumor when relevant and the 
final histological outcome, which is divided into five classes: benign, borderline 
malignant, stage I, stage II-IV, and secondary metastatic cancer. The 5909 patients 
included in the study are randomly split into equally large training and test sets. We 
developed and tested models using the following algorithms: logistic regression, 
support vector machines, k nearest neighbors, random forest, naive Bayes and 
nearest shrunken centroids.  
 
Multiclass calibration plots are interesting as an approach to visualizing the reliability 
of predicted risks. The ECI is a convenient tool for comparing models, but is less 
informative and interpretable than calibration plots. In our case study, logistic 
regression and random forest showed the highest degree of calibration, and the 
naive Bayes the lowest. 
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Abbreviations 
 
AUC  Area under the ROC curve 
CI  Confidence Interval 
ECI  Estimated Calibration Index 
IOTA  International Ovarian Tumor Analysis 
IQR  InterQuartile Range 
kNN  k Nearest Neighbor 
LR-BT Logistic Regression Binary Tree – sequential dichotomous model 
LR-PC Logistic Regression Pairwise Coupling 
MLR  Multinomial Logistic Regression 
NB  Naive Bayes 
NSC  Nearest Shrunken Centroids 
PDI  Polytomous Discrimination Index 
RF  Random Forest 
ROC  Receiver Operating Characteristic 
SVM  Support Vector Machines 
SVM-BT Support Vector Machines Binary Tree – sequential dichotomous model 
SVM-PC Support Vector Machines Pairwise Coupling 
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1 Introduction 
 
For medical applications, prediction models that provide probabilistic (risk) estimates 
of an event of interest are useful for clinical decision support, personalized 
healthcare, and shared decision making.  Prior to the implementation of such tools in 
clinical practice, validation with respect to discrimination and calibration is required 
[1-6]. A model needs to be able to distinguish between different possible outcome 
categories (discrimination). How well a model performs this function can be evaluated 
using the area under the receiver operating characteristic curve (AUC) or multiclass 
extensions of this approach. Calibration assessment is often overlooked, but is of 
importance for several applications where risk models may be used. Such 
applications include decisions whether or not to treat a patient [7] start preventive 
action, or to inform the choice of treatment [8] Calibration is also relevant when 
informing patients about risk [9], when comparing hospitals with respect to quality of 
care (e.g. benchmarking based on mortality risk) [10], and when identifying high risk 
patients for inclusion in clinical trials [11]. The optimal use of risk models in these 
situations relies on reliable risk estimation. For example, a classic result from 
decision analysis states that the adopted risk threshold to decide whether or not to 
take further action implies there are relative misclassification costs [12]: the odds of 
the risk threshold equals the ratio of the harm of a false positive test result to the 
benefit of a true positive result. For example if a risk threshold of 10% is adopted, the 
assumption is that 1 true positive is worth 9 false positives. If a poorly calibrated risk 
model is then used to assess whether patients exceed the planned threshold, 
inappropriate decisions may be taken.   
 
For binary outcomes, the relationship between predicted and observed probabilities 
can be visualized by means of a calibration plot [1, 13, 14]. Observed probabilities 
are sometimes obtained by computing event rates within groups of patients with 
similar predicted probabilities (e.g. decile split). However sometimes, flexible 
smoothing methods such as local regression (loess) or splines are used to link 
predicted probabilities to estimated observed probabilities [1].    
 
Recently, our group extended binary calibration plots to multiclass models based on 
multinomial logistic regression (MLR) [15]. For calibration statistics we introduced the 
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concept of multiclass calibration-in-the-large [15]. We proposed two frameworks, one 
parametric and one non-parametric. Logistic regression is a common algorithm to 
build binary and multiclass clinical prediction models, and naturally works with risk 
estimates. However, machine learning algorithms are also used for clinical risk 
prediction [16-21], and are very frequently used in high dimensional and/or “large p, 
small n” prediction studies (i.e. a large number of predictors and a small number of 
patients) [22-24]. Moreover, although using machine-learning approaches for 
classification problems is often less suited to probability estimation, methods do exist 
to facilitate this [25-30]. The calibration performance of risk models is also an issue 
that is often neglected, and it is not surprising that with a few exceptions this is 
frequently the case for models based on machine learning algorithms [13, 26, 27, 30-
32].  
 
The aim of this paper is to introduce a non-parametric framework to evaluate the 
calibration of multiclass risk models irrespective of the modeling technique used. 
Based on this framework we also derive a calibration measure to quantify and 
compare calibration performance between models. We illustrate these methods with 
a case study looking at the classification of ovarian tumors. We develop and validate 
risk models to diagnose tumor pathology based on logistic regression, support vector 
machines, k-nearest neighbors, random forest, naive Bayes and nearest shrunken 
centroids.   
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2 Non-parametric recalibration framework  
 
Our group developed calibration tools for risk models based on multinomial logistic 
regression (MLR) [15]. Assume an MLR or „baseline-category logit‟ model [33] with m 
predictors 1x  to mx  for an outcome with J (j=1, …, J) categories. If category 1 is 
chosen as the reference category, the model is written as 
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and the multiclass risks are obtained as
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Let  21 1lp ,..., lpˆ ˆ J  denote the estimated linear predictors and  1ˆ ˆ,..., Jp p  the estimated 
multiclass risks. The non-parametric recalibration framework for such models relates 
the multiclass outcome Y on the estimated J-1 linear predictors  21 1lp ,..., lpˆ ˆ J  from the 
MLR risk model through a vector spline [34] MLR analysis [15]:  
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with        2 3. . . ... .Js s s s     a vector spline smoother applied to each linear 
predictor [15, 34]. This vector spline smoother  .s   is a natural extension of the cubic 
spline smoother to vector responses and consists of J-1 natural cubic B-splines  .js  
[34, 35]. Similarly as the multiclass risks in (2) are obtained from (1), this framework 
can be used to estimate the observed probabilities  1ˆ ˆ,..., Jo o  (Appendix A) [15]. 
 
If we now consider a generic multiclass risk model (i.e. irrespective of how it was 
developed) yielding risk estimates  1ˆ ˆ,..., Jp p . In order to use the nonparametric 
recalibration model we first calculate  1 1ˆ ˆ ˆlog zj jp p  , with j=2, …, J if category 1 is 
used as reference category. These quantities are used as predictors in the vector 
spline MLR model (3) to estimate the observed probabilities: 
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The observed probabilities ˆ jo  are obtained by using the vector spline MLR model (4) 
and then applying the equations like (2) (Appendix A). Calibration plots are obtained 
by plotting the predicted probabilities ˆ jp  versus the observed probabilities ˆ jo  for 
each outcome category j (j=1,…,J) [15]. Note that there is no one-to-one relationship 
between ˆ jp  and ˆ jo . The reason is that, for a specific value of ˆ jp , predicted 
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probabilities for the other J-1 categories can vary and this will lead to different values 
for ˆ jo .  Therefore, spline smoothers are plotted to assess the trend of the scatter plot 
for each category [15].  
 
To quantify the lack of calibration with a single measure, the correspondence 
between ˆ jp  and ˆ jo  can be assessed through their squared difference averaged over 
J categories and N observations:    
2
1 1
ˆ ˆ
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  
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average squared difference by 100J/2 we obtain a measure that we refer to as the 
Estimated Calibration Index (ECI) because it is based on estimates of the observed 
probabilities  1ˆ ˆ,..., Jo o . The multiplication factor 100J/2 ensures that the ECI has a 
theoretical range between 0 and 100 (Appendix B).   The ECI has similarities to the 
Brier score. However, the Brier score represents the average squared difference 
between the actual outcomes ny  and the predicted probabilities such that it is an 
overall performance measure that captures discrimination and calibration: Brier score 
=    
2
1 1
ˆ
N J
nj njn j
y p N J
 
  
     [36].  In contrast, the ECI is the average squared 
difference of the predicted probabilities ˆ np  with the estimated observed probabilities 
ˆno  instead of the actual outcomes.  
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3 Case-study 
 
The accurate diagnosis of ovarian tumors prior to surgery is crucial when choosing 
appropriate patient management and referral. As different types of malignancies 
require different management, we aimed to develop a model to predict the risk that 
an ovarian tumor is benign, borderline malignant, a stage I cancer, a stage II-IV 
cancer, or secondary metastatic cancer. We used data from the International Ovarian 
Tumor Analysis (IOTA) consortium [37-39]. These data are derived from 5909 
patients collected between 1999 and 2012 at 24 centers in 10 countries [40], and 
were randomly divided into a development and validation set stratified for the final 
outcome. The outcome is based on the histo-pathological diagnosis of the mass after 
surgical removal by laparotomy or laparoscopy as well as the stage of the tumor 
(when relevant) as assessed by the surgeon. Pathologists were blind to the data 
collected for the study and the results of any risk models we developed. The following 
predictors or features were considered for model development without further 
selection: age (years), serum CA125 (U/ml), oncology referral center (yes/no), 
maximum diameter of the lesion (mm), proportion of solid tissue (between 0 and 1), 
presence of more than 10 cyst locules (yes/no), number of papillary projections (0, 1, 
2, 3 and more than 3), presence of acoustic shadows (yes/no) and presence of 
ascites (yes/no) (Table 1). The proportion of solid tissue is defined as the ratio of the 
maximum diameter of the largest solid component and the maximum diameter of the 
lesion. These nine variables are the predictors from the multinomial risk prediction 
model ADNEX [40]. Some values for serum CA125 were missing and were imputed 
in order not to lose these records. We used predictive mean matching regression [41] 
using variables that were either related to the level of CA125 itself, or the 
unavailability of CA125 via an indicator as to whether the CA125 level was missing or 
not [42]. 
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Table 1. Descriptive statistics of the ovarian tumor case study 
 Benign Borderline Stage I Stage II-IV Metastatic 
Outcome, N 3980 339 356 988 246 
Variable, N (%) or median (IQR)      
  Age (years) 42 (32-54) 49 (36-62) 54 (44-64) 59 (50-67) 57 (47-68) 
  Serum CA125 (U/mL)* 19 (11-39) 31 (16-100) 52 (21-190) 447 (147-1215) 81 (30-271) 
  Family history of ovarian cancer,  79 (2.0) 10 (3.0) 13 (3.7) 57 (5.8) 5 (2.0) 
  Maximal diameter of lesion (mm) 63 (45-87) 86 (51-150) 106 (71-153) 85 (56-123) 86 (56-124) 
  Solid tissue      
     Presence of solid tissue 1322 (33.2) 267 (78.8) 328 (92.1) 968 (98.0) 234 (95.1) 
     Proportion solid tissue if present (%)  42 (20-100) 37 (24-59) 61 (38-100) 100 (56-100) 100 (64-100) 
  Number of papillary projections      
     None 3424 (86.0) 135 (39.8) 227 (63.8) 772 (78.1) 213 (86.6) 
     1 333 (8.4) 69 (20.4) 25 (7.0) 56 (5.7) 12 (4.9) 
     2 80 (2.0) 21 (6.2) 17 (4.8) 30 (3.0) 0 (0) 
     3 66 (1.7) 24 (7.1) 17 (4.8) 28 (2.8) 2 (0.8) 
     >3 77 (1.9) 90 (26.5) 70 (19.7) 102 (10.3) 19 (7.7) 
  More than 10 cyst locules 199 (5.0) 74 (21.8) 69 (19.4) 93 (9.4) 36 (14.6) 
  Acoustic shadows 676 (17.0) 8 (2.4) 18 (5.1) 30 (3.0) 10 (4.1) 
  Ascites 64 (1.6) 28 (8.3) 65 (18.3) 473 (47.9) 90 (36.6) 
Missing values for CA125, N (%) 1447 (36.4) 62 (18.3) 71 (19.9) 163 (16.5) 62 (25.2) 
* Results for Serum CA125 are based on single imputation of missing values. 
Abbreviations: IQR; Interquartile Range. 
 
3.1 Study set-up 
 
We develop and validate various binary and multiclass risk models to diagnose 
ovarian tumors. The models are based on logistic regression and machine learning 
algorithms (see Appendix B). In the first part of the study, we develop binary models 
to distinguish between benign and malignant tumors. We then discuss multiclass 
problems by developing models to distinguish between benign, borderline malignant, 
stage I invasive, stage II-IV invasive and secondary metastatic ovarian tumors. The 
available data were split into a development set and a validation set. The split was 
random, using a 1:1 ratio with stratification according to the multiclass outcome. R 
version 3.0.3 (www.r-project.org) was used for the statistical analysis. 
 
3.2 Performance evaluation 
 
The ability to distinguish between different outcome categories (discrimination) as 
well as the reliability of predicted risks (calibration) is assessed.  
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3.2.1 Discrimination  
Discrimination of a binary risk prediction model was evaluated using the area under 
the ROC curve (AUC) [43]. For the multiclass risk models, several measures were 
used that are related to the AUC. First, we calculated AUCs for pairs of categories 
based on conditional risks (e.g. riskA/(riskA+riskB), where riskA and riskB are the 
estimated risks for categories A and B) [44]. Two multiclass AUCs variants were also 
evaluated: the M-index and Polytomous Discrimination Index (PDI) [45, 46]. The M-
index is an average of pairwise AUCs, where the pairwise AUC for categories A and 
B is the average of the AUC based on riskA and the AUC of riskB (these two AUCs 
are not the same because riskA+riskB≠1) [45]. The PDI is a direct multiclass version 
of the AUC and estimates the average proportion of correctly identified cases within a 
group of cases each belonging to a different outcome category [46]. For J outcome 
categories the value of M-index and PDI for a model that gives random predictions is 
0.5 and 1/J (e.g. 0.2 if J=5) [46].  
 
3.2.2 Calibration  
As an overall group-level measure we calculated the calibration-in-the-large or mean 
calibration for every outcome category. This measure equates to the difference 
between the observed event rate of an outcome category and the average predicted 
probability of this category (i.e. the predicted event rate). For the assessment of the 
calibration of individual risk predictions we used the non-parametric recalibration 
framework explained in Section 2 to produce calibration plots and to calculate ECI. 
  
3.3 Overview of the implemented approaches 
 
In the first part of the study we focus on the binary diagnosis of ovarian tumors as 
benign or malignant. The binary risk models were logistic regression, support vector 
machines, k nearest neighbors, random forest, naive bayes and nearest shrunken 
centroids [47-51] (Table 2). More information concerning the different models and the 
tuning of the hyperparameters is given in Appendix C.  
 
In the second part we focus on the multiclass diagnosis of ovarian tumors as benign, 
borderline malignant, stage I cancer, stage II-IV cancer, or secondary metastatic 
cancer. Multiclass risk models can either be a combination of binary risk models or 
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an „all-in-one‟ model. Among the algorithms we implemented, only the SVMs could 
not give all-in-one multiclass risks. When binary models were combined, two types of 
combinations were used: a tree of nested dichotomies (or binary tree) [52], and 
pairwise coupling [53]. For the former a tree of binary prediction models is 
constructed. In our case study, from a clinical viewpoint the first two dichotomies of 
the binary tree are straightforward: first a model to distinguish between benign and 
malignant tumors, then for the malignant tumors a model to distinguish between 
borderline and invasive tumors. The invasive tumor category has three subgroups: 
stage I, stage II-IV and secondary metastatic cancers. Since it is less obvious what 
the most clinically relevant tree is for these three categories, we constructed three 
possible trees and computed the average (Figure 1).  For pairwise coupling, the 
pairwise probabilities ˆ ijp  of every pairwise model i versus j are combined in order to 
obtain multiclass probabilities ˆ ip  (i=1,…,J) by solving the following system: 
 1, ˆ1
J
i i j ijj j i
p p p J p
 
     , for all i with 1 1
J
ii
p

  and 0ip   [54]. 
 
Figure 1. The three different considered sequential dichotomous models or binary 
trees. 
 
For multiclass risk prediction, we applied nine algorithms (Table 2). For logistic 
regression, all-in-one multinomial logistic regression (MLR), sequential dichotomous 
logistic regression (LR-BT) and pairwise coupling logistic regression (LR-PC) were 
used. For support vector machines, a binary tree (SVM-BT) and a pairwise coupling 
(SVM-PC) approach were applied. 
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Table 2. Overview of the binary and multiclass approaches considered. 
Binary Multiclass 
 all-at-once binary tree pairwise coupling 
LR MLR LR-BT LR-PC 
SVM - SVM-BT SVM-PC 
KNN KNN - - 
RF RF - - 
NB NB - - 
NSC NSC - - 
 
 
3.4 Model comparison based on ECI 
 
Confidence intervals for ECI and the ECI difference between two models were 
obtained with bootstrapping using the bias-corrected method on 1000 bootstrap 
samples of the validation data. We always reported 95% confidence intervals, 
however we used the following procedure to test for differences between models with 
respect to calibration. We ranked the models based on their validation data ECI, and 
compared the best model with every other model. A correction for multiple testing 
was used using a method similar to the Holm step-down method. We compared the 
best model with the worst model using α=0.05/(m-1), where m is the number of 
models. If significant, the best model is compared with the second to worst model 
using α=0.05/(m-2), and so on. Once a test is not statistically significant, all remaining 
tests are considered not significant as well. 
 
3.5 Software 
 
For the logistic regression and machine learning models we used the following R-
packages: rms, vgam, klaR, pamr, randomForest, kernlab and caret. The 
function sigest() of the R-package kernlab is used for automatic sigma estimation, 
while the functions train() and trainControl() of the R-package caret were 
used for the determination of optimal tuning parameters.  
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4 Results 
 
4.1 Binary outcome 
 
The optimal hyperparameter values based on maximizing the accuracy and  
minimizing the logloss were different for the SVM regularization parameter C (10 
based on accuracy vs 1 based on logloss) and for the number of neighbors for kNN 
(20 vs 50). Minimizing the logloss resulted in a simpler model compared with 
maximizing accuracy. This implies less over-fitting and smoother results, which 
means that better calibration performance can be expected. 
 
The validation AUCs demonstrated good discrimination for all approaches (Table 3). 
kNN had the worst discriminative ability with a validation AUC of 0.890, RF the best 
with a validation AUC of 0.948.   
 
 
Table 3. Discrimination (AUC) and calibration (mean calibration (in %) of the risk of 
malignancy and estimated calibration index (ECI)) performance of the binary 
prediction models on the validation data. 
Model (selection 
criterion) 
Discrimination Calibration 
AUC 
Mean 
calibration 
ECI 
LR 0.938 0.25 0.01 
SVM (accuracy) 0.940 0.94 0.09 
SVM (logloss) 0.945 0.40 0.04 
kNN (accuracy) 0.860 1.80 0.61 
kNN (logloss) 0.862 1.92 0.05 
RF (accuracy) 0.948 1.64 0.05 
RF (logloss) 0.948 1.64 0.05 
NB (accuracy) 0.910 3.93 1.67 
NB (logloss) 0.910 3.93 1.67 
NSC (accuracy) 0.890 2.47 0.45 
NSC (logloss) 0.890 2.47 0.45 
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The mean calibration of the risk of malignancy was close to zero for logistic 
regression. Overall it ranged between 0.25% (logistic regression) and 3.93% (naive 
Bayes) on the validation data suggesting that the risk of malignancy was on average 
slightly underestimated (Table 3). Most models showed an ECI close to zero, 
exceptions based on accuracy were kNN, NB, and NSC (Table 3). Logistic 
regression had the best ECI. Ranking models based on mean calibration or ECI 
yields different results, which is explained by the fact that these measures do not 
capture the same information. In general terms the mean calibration measures 
calibration on the group level whereas ECI focuses on the individual level. For 
example, kNN based on logloss has relatively poor mean calibration but a relatively 
good ECI.  
 
The calibration plots for logistic regression (lowest ECI) and NB (highest ECI) are 
shown in Figure 2 a-b. We have plotted the curves for the risk of a benign tumor and 
for the risk of malignancy, even though plotting only one would be sufficient because 
both curves are complementary. The reason we have shown both curves is to make 
the plots consistent with the calibration plots for multiclass models, where it is 
convenient to show curves for every category. It is interesting to observe that the ECI 
value of 1.67 for NB corresponded to calibration curves that are very deviant from the 
(ideal) diagonal line. Although 1.67 appears close to 0, the NB model is not well 
calibrated.  
 
For SVM and kNN, different hyperparameters were selected when relying on logloss 
vs accuracy as a selection criterion. As expected, models based on logloss showed 
better calibration. This is illustrated in Figure 2c-d for kNN. A similar yet less explicit 
difference was observed for SVM.  
 
Figure 2. Calibration plot of the validation data for (a) dichotomous logistic 
regression, (b) binary naive Bayes, (c) k nearest neighbors with maximizing accuracy 
and (d) minimizing logloss as selection criterion. 
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4.2 Multiclass outcome 
 
For all machine learning approaches except RF, hyperparameter values obtained by 
maximizing accuracy were different from the values obtained by minimizing logloss 
resulting in different risk probabilities.  
 
The best multiclass AUC results were obtained for the logistic regression models 
(0.790-0.798) and RF (0.792), the worst for kNN (0.684-0.686) (Table 4). Regarding 
pairwise AUCs (Table S1), it was clear that it was most difficult to distinguish 
between borderline and stage I cancer, and between the different types of invasive 
cancers (stage I, stage II-IV, and secondary metastatic cancer).     
  
 
Table 4. Discrimination, i.e. M-index and polytomous discrimination index PDI, for the 
multiclass prediction models using the validation data. 
Model (selection 
criterion) 
Discrimination Calibration 
M-index PDI ECI (95%CI) 
MLR 0.790 0.529 0.27 [0.13;0.36] 
LR-BT 0.798 0.542 0.30 [0.18;0.38] 
LR-PC 0.795 0.537 0.26 [0.18;0.32] 
SVM-BT (acc) 0.755 0.482 0.51 [0.31;0.61] 
SVM-BT (ll) 0.770 0.505 0.38 [0.26;0.48] 
SVM-PC (acc) 0.764 0.467 0.76 [0.59;0.87] 
SVM-PC (ll) 0.764 0.469 0.81 [0.64;0.93] 
kNN (acc) 0.684 0.403 0.76 [0.56;0.94] 
kNN (ll) 0.686 0.399 0.28 [0.18;0.33] 
RF (acc) 0.792 0.539 0.40 [0.23;0.48] 
RF (ll) 0.792 0.539 0.40 [0.23;0.48] 
NB (acc) 0.742 0.451 8.25 [7.66;8.76] 
NB (ll) 0.768 0.495 4.82 [4.26;5.39] 
NSC (acc) 0.754 0.470 1.42 [1.11;1.63] 
NSC (ll) 0.753 0.471 1.19 [0.91;1.39] 
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Overall the logistic regression approaches had the best mean calibration, while NB 
was clearly worse, specifically when accuracy was used to tune the hyperparameter 
(Table S2). This is remarkable given that the available data were randomly split into 
development and validation sets. For the other models the deviation was mild (up to 
4%). The ECI was lowest for the logistic regression approaches (0.26-0.30) and kNN 
based on logloss (0.28), and highest for NB (4.82 when based on logloss, 8.25 when 
based on accuracy) (Table 4). When comparing the ECI of the best model LR-PC 
with those of every other model, with the application of a Holm-based step-down 
method to correct for multiple testing, we conclude that there is no statistically 
significant difference between the ECI of LR-PC and the ECI‟s of MLR, LR-BT, SVM-
BT based on logloss, kNN based on logloss, and RF (Table 5). The other models‟ 
ECI was significantly lower.  
 
The multiclass calibration plots of the best calibrated models according to ECI (LR-
PC as the best logistic regression model, SVM-BT based on logloss as the best SVM 
model, RF, and kNN based on logloss) are shown in Figure 3. As highlighted in 
section 2,, contrary to the calibration plots for binary outcomes, there is no one-to-
one relationship between predicted and observed probabilities. For that reason we 
added spline smoothers to summarize the trend. In Figure 4 simplified calibration 
plots with only the smoothed curves are shown. All models are fairly well calibrated. 
The most clear deviation is that higher estimated risks for the small categories 
(borderline, stage I cancer, secondary metastatic cancer) are typically too extreme 
(overfitted) as the curves for these outcome categories deviate more from the 
diagonal as the predicted probability increases.  
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Table 5. Model comparison based on the difference in ECI (with 95% confidence 
intervals) using the validation data. In the first part, the ECI of each model is 
compared with the ECI of the best model (LR-PC). Models for which there is a 
statistically significant difference with LR-PC after correction for multiple testing are 
identified with an asterisk. In the second part, the ECI values of each machine 
learning model with hyperparameter tuning based on accuracy and logloss are 
compared.  
Model comparison  ECI (95% CI) 
Each model vs the best (LR-PC)  
  MLR vs LR-PC  0.01 [-0.05;0.07] 
  kNN (ll) vs LR-PC  0.02 [-0.10;0.17] 
  LR-BT vs LR-PC  0.03 [-0.02,0.10] 
  SVM-BT (ll) vs LR-PC 0.12 [0.01;0.24] 
  RF (acc) vs LR-PC 0.14 [0.02;0.29] 
  RF (ll) vs LR-PC 0.14 [0.02;0.29] 
  SVM-BT (acc) vs LR-PC 0.25 [0.09;0.40]* 
  kNN (acc) vs LR-PC 0.50 [0.28;0.75]* 
  SVM-PC (acc) vs LR-PC 0.49 [0.32;0.67]* 
  SVM-PC (ll) vs LR-PC 0.55 [0.37;0.72]* 
  NSC (ll) vs LR-PC 0.93 [0.72;1.15]* 
  NSC (acc) vs LR-PC 1.15 [0.94;1.40]* 
  NB (ll) vs LR-PC 4.55 [4.06;5.17]* 
  NB (acc) vs LR-PC 7.99 [7.45;8.59]* 
Accuracy versus logloss  
  SVM-PC: acc vs ll -0.05 [-0.14;0.05] 
  SVM-BT: acc vs ll 0.13 [0.01;0.25] 
  NSC: acc vs ll 0.22 [0.17;0.29] 
  kNN: acc vs ll 0.47 [0.33;0.63] 
  NB: acc vs ll 3.44 [2.59;4.20] 
 
Figure 3. Multiclass calibration plot with smoother using the validation data for (a) 
pairwise coupling logistic regression model, (b) binary tree support vector machines 
19 
 
with minimizing logloss as selection criterion, (c) random forest and (d) k nearest 
neighbors with minimizing logloss as selection criterion.  
 
Figure 4. Smoothed multiclass calibration plot using the validation data for (a) 
pairwise coupling logistic regression model, (b) binary tree support vector machines 
with minimizing logloss as selection criterion, (c) random forest and (d) k nearest 
neighbors with minimizing logloss as selection criterion.  
 
The ECI was always lower when hyperparameter tuning was based on logloss 
compared with accuracy, except for SVM-PC where results were nearly identical for 
both methods (Table 4). For four algorithms (SVM-BT, kNN, NSC, NB), the 95% 
confidence interval on the ECI difference did not include 0 (Table 5). Even if we were 
to correct for multiple testing, significant differences would remain except for SVM-
BT. Hence minimization of logloss resulted in better calibration, which is illustrated for 
kNN and NB in Figure 5. This figure also shows the clear miscalibration of risks 
based on NB, even when logloss was used. 
 
Figure 5. Smoothed multiclass calibration plot using the validation data for k nearest 
neighbors (a-b) and naive Bayes (c-d) with maximizing accuracy and minimizing 
logloss as selection criterion.  
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5 Discussion  
 
When validating a risk model for medical applications, discrimination as well as 
calibration should be assessed [1-6]. The model needs to be able to distinguish the 
different outcome categories but also to reliably predict the risk of a certain outcome. 
In this paper we have described a generic recalibration framework to visualize and 
quantify the lack of calibration for multiclass risk models irrespective of the modeling 
approach used. To illustrate this we have used the diagnosis of ovarian tumors as a 
case study. Different models were developed and validated with respect to 
discrimination and calibration: logistic regression, support vector machines, k nearest 
neighbors, random forest, naive Bayes and nearest shrunken centroids. Overall, 
logistic regression and random forest models showed the best calibration, whereas 
the calibration of naive Bayes was disappointing. An explanation for the latter might 
be that the independence assumption is unrealistic for the data leading to inaccurate 
estimates [55].  
 
5.1 Visualization versus quantification of calibration 
 
The recalibration framework was used to visualize calibration by means of a 
calibration plot as well as to quantify the lack of calibration through the estimated 
calibration index (ECI). The ECI focuses on calibration of individual patient risks, and 
therefore has an advantage over mean calibration, which is a group level measure. 
Mean calibration assesses whether estimated event rates are accurate. Lack of 
mean calibration is also captured by ECI, but ECI captures other aspects as well 
such as over-fitting (risk estimates that are too extreme).  
 
Both visualization and quantification have their advantages and disadvantages. 
Calibration plots are more informative and interpretable than ECI, because ECI 
summarizes the calibration plot for every outcome into a single number. Therefore, 
for the evaluation of a single model one should focus on calibration plots. The ECI 
should not be used as a stand-alone metric in this situation because the result is hard 
to interpret without corresponding plots. The well-known Hosmer-Lemeshow 
goodness-of-fit test and its extensions are often used to evaluate miscalibration of a 
single model. Hosmer-Lemeshow statistics were not discussed in this paper due to 
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reported drawbacks with their use such as instability, low power, sensitivity to sample 
size and arbitrariness of the construction of subgroups [56, 57]. If the aim is to 
compare multiple models, however, ECI can be used. Given that ECI compares 
predicted probabilities with observed probabilities that are in fact estimated, we 
advise bootstrapping to obtain confidence intervals or to test for a statistically 
significant difference between models. We always have to keep in mind that two 
models with the same ECI may have different calibration curves and thus a different 
type of miscalibration.  
 
Since there is no one-to-one relationship between predicted and observed 
probabilities for the multiclass calibration plots (see Figure 3) we use smoothed 
curves to visualize the general relationship. If only the smoothed curves are shown 
(as we did in Figures 4-5 for clarity), information is lost. Nevertheless, we believe 
these smoothed relationship is most important in the assessment of calibration 
performance. Yet if this relationship is good, meaning that it is close to the diagonal 
line, it is still possible that predicted and observed probabilities are away from the 
diagonal line for many patients. So far, it is our experience that it is very difficult to 
develop a model where, the result for every patient in a validation dataset is close to 
the diagonal line. Further research on this issue is needed.  
 
5.2 Tuning: logistic regression versus machine learning 
 
The tuning of risk prediction models is an important issue [26]. For logistic regression, 
variable selection, non-linear effects and interaction terms can be considered as 
tuning [26]. We have not investigated the inclusion of non-linear effects or 
interactions, although non-linear effects are probably present [58]. In real clinical 
applications such tuning is advised, for example by modeling continuous predictors 
using spline functions, however the amount of tuning should depend on the sample 
size that is available [58]. Machine learning approaches have different tuning 
parameters (e.g. number of neighbors for kNN and number of considered variables in 
each split for RF) [26]. The choice of optimization method for these hyperparameters 
may influence model performance [31]. As expected, we noticed in our study that 
considering logloss as an optimization method for tuning resulted in better calibration 
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compared with accuracy. We acknowledge that other optimization methods can be 
considered and may yield different model performance [31]. 
 
5.3 Choice of algorithms 
 
In the literature, many machine-learning models are available and the optimal 
hyperparameter values of these models can be obtained using different optimization 
techniques. Different methods can be used to create probabilities, certainly for 
multiclass outcomes [25, 28]. This results in a plethora of possible algorithms to 
develop binary and multiclass risk models. In this paper we considered some 
approaches as an illustration of the multiclass calibration tools that may be used. We 
did not attempt to compare algorithms with respect to their capacity to produce 
calibrated risk estimates.  The latter would be of interest, but to do this we believe 
that a large benchmark study would be required to compare a large battery of 
algorithms on multiple datasets. 
 
 
5.4 Further practical limitations  
 
We compared different degrees of freedom for the vector splines in the vector spline 
MLR analysis, and concluded that 2 degrees of freedom were sufficient [15]. 
Procedures for automatic selection of the level of smoothing for the calibration plots, 
for example by using generalized cross validation, would be desirable [59]. 
 
We randomly divided the data into development and validation data, with stratification 
for the multiclass outcome. This random split allowed the construction of calibration 
plots, but the results may depend on the split. However we expect that the 
dependency is limited due to the large sample size. Also, in real applications it is 
more interesting to use an external validation dataset, for example by using new data 
collected later in time or data from different hospitals. An advantage of using such a 
random split is that it should lead to few problems with mean calibration, because the 
development and validation are two random samples from an identical population. 
Miscalibration in our case study was more likely to be related to over-fitting. 
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Another limitation is that we decided to use single imputation for CA125. This 
approach ignores the fact that we are uncertain about whether the imputed values 
are correct [42]. An alternative to deal with the issue of uncertainty would be multiple 
imputation [42]. However, since the aim of this study was not the development of risk 
prediction models for clinical practice, we made a pragmatic decision to use single 
imputation.  
 
5.5 General conclusions 
 
The generic recalibration framework is an interesting approach to visualizing the 
reliability of predicted risks and quantify lack of calibration. The estimated calibration 
index (ECI) is easy for comparing models, but is less informative and interpretable 
than calibration plots. 
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Figure 1: The three different considered sequential dichotomous models or
binary trees.
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Figure 2: Calibration plot of the validation data for (a) dichotomous logistic
regression, (b) binary naive Bayes, (c) k nearest neighbors with maximizing
accuracy and (d) minimizing logloss as selection criterion.
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(b) SVM-BT (logloss)
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Figure 3: Multiclass calibration plot with smoother of the validation data
for (a) pairwise coupling logistic regression model, (b) binary tree support
vector machines with logloss as optimization method, (c) random forest and
(d) k nearest neighbors with logloss as optimization method.
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(b) SVM-BT (logloss)
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Figure 4: Smoothed multiclass calibration plot of the validation data for (a)
pairwise coupling logistic regression model, (b) binary tree support vector
machines with logloss as optimization method, (c) random forest and (d) k
nearest neighbors with logloss as optimization method.
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(a) kNN (accuracy)
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(b) kNN (logloss)
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(c) NB (accuracy)
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Figure 5: Smoothed multiclass calibration plot of the validation data for k
nearest neighbors (a-b) and naive Bayes (c-d) with accuracy and logloss as
optimization method.
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Table S1. Conditional pairwise AUCs for the multiclass prediction models for the validation data. 
 
Model  
(selection criterion) 
Be vs Bo Be vs St1 Be vs St24 Be vs Met Bo vs St1 Bo vs St24 Bo vs Met St1 vs St24 St1 vs Met St24 vs Met 
MLR 0.887 0.917 0.964 0.950 0.702 0.881 0.893 0.773 0.722 0.684 
LR-BT 0.887 0.920 0.967 0.949 0.724 0.881 0.883 0.782 0.724 0.704 
LR-PC 0.883 0.919 0.966 0.950 0.710 0.881 0.886 0.780 0.730 0.698 
SVM-BT (accuracy) 0.821 0.919 0.975 0.949 0.708 0.847 0.831 0.756 0.717 0.604 
SVM-BT (logloss) 0.889 0.919 0.973 0.952 0.708 0.864 0.849 0.751 0.676 0.595 
SVM-PC (accuracy) 0.710 0.887 0.973 0.937 0.733 0.895 0.898 0.746 0.744 0.594 
SVM-PC (logloss) 0.701 0.896 0.974 0.928 0.730 0.895 0.888 0.746 0.724 0.608 
kNN (accuracy) 0.683 0.784 0.945 0.797 0.589 0.799 0.622 0.750 0.517 0.669 
kNN (logloss) 0.676 0.805 0.945 0.811 0.583 0.824 0.632 0.797 0.577 0.698 
RF (accuracy) 0.880 0.919 0.983 0.929 0.748 0.912 0.864 0.793 0.676 0.695 
RF (logloss) 0.880 0.919 0.983 0.929 0.748 0.912 0.864 0.793 0.676 0.695 
NB (accuracy) 0.867 0.887 0.973 0.932 0.720 0.895 0.892 0.785 0.742 0.693 
NB (logloss) 0.868 0.874 0.955 0.920 0.680 0.868 0.864 0.762 0.696 0.604 
NSC (accuracy) 0.846 0.855 0.935 0.897 0.671 0.848 0.876 0.744 0.726 0.674 
NSC (logloss) 0.844 0.859 0.937 0.898 0.679 0.850 0.880 0.743 0.728 0.674 
Abbreviations: Be, benign; Bo, borderline; St1, Stage I; St24, Stage II-IV; Met, Metastatic. 
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Table S2. Mean calibration for the multiclass prediction models for the validation 
data. 
 
Model (selection criterion) Benign Borderline Stage I Stage II-IV Metastatic 
MLR -0.13 -0.10 -0.16 0.37 0.03 
LR-BT -0.25 -0.31 -0.08 0.77 -0.13 
LR-PC -0.25 -0.40 -0.08 0.73 0.00 
SVM-BT (accuracy) -0.94 -0.80 0.14 1.51 -0.19 
SVM-BT (logloss) -0.40 0.01 -0.23 0.70 -0.40 
SVM-PC (accuracy) 2.13 -1.63 -1.10 0.89 -0.29 
SVM-PC (logloss) 2.10 -1.67 -1.01 0.86 -0.27 
kNN (accuracy) -1.74 0.58 0.45 0.54 0.17 
kNN (logloss) -1.92 0.52 0.57 0.61 0.21 
RF (accuracy) -3.35 1.10 1.31 -0.38 1.31 
RF (logloss) -3.35 1.10 1.31 -0.38 1.31 
NB (accuracy) -22.60 4.90 5.49 8.44 3.77 
NB (logloss) -0.48 -4.00 -0.45 5.81 -0.88 
NSC (accuracy) -2.80 0.10 -0.36 2.89 0.16 
NSC (logloss) -3.52 0.20 -0.27 3.28 0.31 
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